English | Español
Patient Daily | Dec 9, 2025

UK agrees to pay more for drugs in exchange for tariff exemption
Patient Daily | Dec 9, 2025

UTHealth Houston surgeon treats rare facial pain disorder for El Paso woman
Patient Daily | Dec 8, 2025

Rare disease experts urge consistent FDA policies amid mixed approvals
Patient Daily | Dec 8, 2025

How clothing choices affect physical health according to Ohio State physicians
Patient Daily | Dec 8, 2025

CRISPR-based Cellgorithm from Syntax Bio may speed up development of stem cell therapies
Patient Daily | Dec 8, 2025

Study finds bedside nurses divided on impact of hospital virtual nursing
Patient Daily | Dec 8, 2025

Baylor College of Medicine joins national AI-driven project on drug safety assessment
Patient Daily | Dec 8, 2025

Restrictive abortion laws linked to rise in EMTALA violations for pregnancy emergencies

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor